J T Kemshead

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.

L. S. Lashford, Ian Lewis, S. Fielding et al. · Journal of Clinical Oncology · 1992 · 162 citations

Medicine, Nuclear Medicine, Oncology +17

USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERS

J T Kemshead · The Lancet · 1983 · 130 citations

Pharmacy, Oncology, Pathology +9

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations

J T Kemshead, L. S. Heath, F. M. Gibson et al. · British Journal of Cancer · 1986 · 101 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +11

Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study

S. Fielding, M. A. Flower, D. M. Ackery et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1991 · 70 citations

Medicine, Nuclear Medicine, Oncology +13

Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund.

Nigel Courtenay-Luck, A. A. Epenetos, K.E. Halnan et al. · PubMed · 1984 · 70 citations

Medicine, Oncology, Radiation Oncology +7